This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ibio Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: James Talmage Taylor, Jr.: Innovator in Cancer Treatment
Introduction
James Talmage Taylor, Jr. is a notable inventor based in College Station, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic antibodies.
Latest Patents
James Talmage Taylor, Jr. holds a patent for an Anti-CD-25 antibody. This patent encompasses materials and methods for using polypeptides containing fragments and variants of the antibody that bind CD25 to treat cancer, either alone or in combination with other anti-neoplastic agents. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Taylor is currently associated with iBio Limited, where he continues to work on groundbreaking research in the field of biotechnology. His role at the company allows him to contribute to the development of innovative treatments that have the potential to improve patient outcomes.
Collaborations
Throughout his career, James has collaborated with talented individuals such as Dillon Phan and Martin Brenner. These partnerships have fostered an environment of innovation and creativity, leading to advancements in cancer therapies.
Conclusion
James Talmage Taylor, Jr. is a dedicated inventor whose work in developing anti-CD-25 antibodies represents a significant step forward in cancer treatment. His contributions to the field highlight the importance of innovation in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile